S3ADHD DIAGNOSTIC & GENETIC HETEROGENEITY IN THE IPSYCH CASE-COHORT STUDY

Sonja LaBianca(Mental Health Services), Thomas Werge(Sankt Hans Hospital), Søren Dalsgaard(Lundbeck Foundation), Isabell Brikell(Aarhus University), Andrew J. Schork(University of California, San Diego), Dorte Helenius(Mental Health Services)
European Neuropsychopharmacology
September 27, 2019
10.1016/j.euroneuro.2019.08.004
Cited by 0

Related Papers

Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
|Nature Genetics|2018|2.3k
Common variants conferring risk of schizophrenia
|Nature|2009|1.7k
The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder
|Neuroscience & Biobehavioral Reviews|2021|1.4k
Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis
|The Lancet Psychiatry|2017|884
Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains
|Nature Genetics|2023|755